Noramco Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Noramco Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10889
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The company’s products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate, buprenorphine base, buprenorphine HCL, hydromorphone HCL, methylphenidate HCL, naloxone HCL, oxycodone base, and oxymorphone HCL products. It also manufactures thebaine, oripavine, oxycodone, hydrocodone, hydromorphone, oxymorphone, buprenorphinr and Nal components. Noramoco offers services such as global supply chain services, manufacturing facilities operations, robust processing, patent protected technology, product designing and development, and customer support services. The company has its presence in the US, Switzerland, the UK, Belgium, and Australia. Noramco is headquartered in Wilmington, Delaware, the US.

Noramco Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noramco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Noramco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Noramco Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
SK Capital Partners Acquires Noramco 10
Partnerships 11
RespireRx Pharma Enters into Agreement Noramco 11
Noramco and SPI Pharma Enter into Agreement 12
Noramco Inc – Key Competitors 13
Noramco Inc – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Noramco Inc, Pharmaceuticals & Healthcare, Key Facts 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noramco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noramco Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Noramco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SK Capital Partners Acquires Noramco 10
RespireRx Pharma Enters into Agreement Noramco 11
Noramco and SPI Pharma Enter into Agreement 12
Noramco Inc, Key Competitors 13

List of Figures
Noramco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noramco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noramco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Noramco Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Euro-Diagnostica AB-医療機器分野:企業M&A・提携分析
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers product …
  • Biomnis SELAS:医療機器:M&Aディール及び事業提携情報
    Summary Biomnis SELAS (Biomnis), a subsidiary of Eurofins Scientific SE, is a provider of medical laboratory testing services. The company offers laboratory tests in the areas of generics, biochemistry, immunology, cytogenics, assisted reproductive technology-embrology-sperm science, onco-haemotolog …
  • AnaptysBio Inc (ANAB):製薬・医療:M&Aディール及び事業提携情報
    Summary AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody product candidates for the treatment of inflammatory, autoimmune and atopic diseases. The company develops its product candidates through its proprietary antibody discovery techn …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Vallourec SA:企業のM&A・事業提携・投資動向
    Vallourec SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vallourec SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Bajaj Corp Limited:戦略・SWOT・企業財務分析
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Delaware Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Delaware Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Energy Development Corp (EDC):電力:M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • Vascular Biogenics Ltd (VBLT):企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL Therapeutics) is a biopharmaceutical company. It discovers, develops and commercializes gene-therapy medicines for the treatment of cancer and inflammatory diseases. The company’s lead product candidate VB-111, a gene-based biologic agent is developed to treat rec …
  • Cadence Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Cadence Biomedical Inc (Cadence), formerly Empowering Engineering Technologies Corp, is a medical device company that provides mobility products. The company offers product such as Kickstart walking system. It provides product to individuals with severe mobility impairments. Cadence’s produc …
  • Mediobanca – Banca di Credito Finanziario SpA (MB):企業の財務・戦略的SWOT分析
    Mediobanca - Banca di Credito Finanziario SpA (MB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Colorado State University-製薬・医療分野:企業M&A・提携分析
    Summary Colorado State University (CSU) is a public research university that offers various academic programs. It provides graduate degree programs, undergraduate degree programs, research programs, summer programs and honor programs. Its schools and programs include graduate school, international p …
  • API Technologies Corp.:戦略・SWOT・企業財務分析
    API Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary API Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • City of Hope-製薬・医療分野:企業M&A・提携分析
    Summary City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation servic …
  • Emera Inc (EMA):企業の財務・戦略的SWOT分析
    Emera Inc (EMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Joslin Diabetes Center-製薬・医療分野:企業M&A・提携分析
    Summary Joslin Diabetes Center (Joslin) is a healthcare service provider that provides diabetes treatment, research and education services. The centers services include weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult diabetic …
  • ConocoPhillips Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    ConocoPhillips Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liqui …
  • Blueprint Medicines Corp (BPMC):製薬・医療:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Zoologischer Garten Berlin AG:企業の戦略・SWOT・財務情報
    Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report Summary Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Armed Forces Insurance:企業の戦略的SWOT分析
    Armed Forces Insurance - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆